Latest Breaking News On - Caremark partd services - Page 1 : comparemela.com

On July 11, 2022, the United States District Court for the District of Kansas approved a $264 million settlement against Mylan and certain of its subsidiaries in the case In Re EpiPen.

United statesNew jerseyDey pharmaEricc tostrudOptum incUnited healthcare incScripts holding companyCaremark partd servicesUnited states district courtUnited health group incRochester drug coPfizer incUnited healthcare services incHealth corporationDakota drug incOptumrx holdings